Palatin Technologies grants director stock options at $21.38 strike

Palatin Technologies, Inc. director equity grant disclosure: A Palatin Technologies director reported receiving two stock option grants on December 9, 2025 under the company’s 2011 Stock Incentive Plan.

Rhea-AI Filing Summary

Palatin Technologies, Inc. director equity grant disclosure: A Palatin Technologies director reported receiving two stock option grants on December 9, 2025 under the company’s 2011 Stock Incentive Plan. Each option is a right to buy 2,400 shares of common stock at an exercise price of $21.38 per share, with both grants expiring on December 9, 2035.

One option grant vests on December 9, 2026, but if the director does not serve through December 31, 2026, it is prorated at 1/12 per month from January 31, 2026. The second option grant vests as to 50% on December 9, 2026 and the remaining 50% on December 9, 2027. Following these grants, the director beneficially owns 5,927 derivative securities in the form of stock options, all held directly.

Insider Trade Summary

Grant/Award: 4,800 shares

Grant/Award 2 txns

Insider Morris Arlene

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	2,400	$0.00	$0.00
Grant/Award	Stock Option (Right to Buy)	2,400	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 5,927 contracts (Direct)

Footnotes (2)

1. F1. Stock Options granted under the 2011 Stock Incentive Plan, the option vests on December 9, 2026, and in the event that the director does not serve until December 31, 2026, is prorated based on the period of service at the rate of 1/12 per month on the last day of each month, starting on January 31, 2026. The options were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of options.
2. F2. Stock Options granted under the 2011 Stock Incentive Plan, the option vests as to 50% on December 9, 2026 and as to the remaining 50% on December 9, 2027. The options were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of options.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Palatin Technologies (PTN) report in this Form 4?

The filing reports two stock option grants to a Palatin Technologies director on December 9, 2025, each covering 2,400 shares of common stock.

What is the exercise price of the new Palatin Technologies (PTN) director stock options?

Each stock option grant gives the director the right to buy common stock at an exercise price of $21.38 per share.

How do the new Palatin Technologies (PTN) director options vest?

One grant vests fully on December 9, 2026 but is prorated monthly at 1/12 if service ends before December 31, 2026. The second grant vests 50% on December 9, 2026 and 50% on December 9, 2027.

When do the Palatin Technologies (PTN) director stock options expire?

Both option grants expire on December 9, 2035 as disclosed in the derivative securities table.

How many Palatin Technologies (PTN) stock options does the director own after these grants?

After the reported transactions, the director beneficially owns 5,927 stock options, all reported as held directly.

Under which plan were the Palatin Technologies (PTN) director options granted?

Both option grants were made under Palatin Technologies’ 2011 Stock Incentive Plan, as stated in the explanation of responses.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/11/2025 - 05:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morris Arlene

(Last) (First) (Middle)

PALATIN TECHNOLOGIES, INC.

11 DEER PARK DRIVE, SUITE 204

(Street)

MONMOUTH JUNCTION, NJ 08852

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PALATIN TECHNOLOGIES INC [ PTN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$21.38	12/09/2025		A		2,400		12/09/2026(1)	12/09/2035	Common Stock	2,400	$0	3,527	D
Stock Option (Right to Buy)	$21.38	12/09/2025		A		2,400		12/09/2026(2)	12/09/2035	Common Stock	2,400	$0	5,927	D

Explanation of Responses:

1. Stock Options granted under the 2011 Stock Incentive Plan, the option vests on December 9, 2026, and in the event that the director does not serve until December 31, 2026, is prorated based on the period of service at the rate of 1/12 per month on the last day of each month, starting on January 31, 2026. The options were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of options.

2. Stock Options granted under the 2011 Stock Incentive Plan, the option vests as to 50% on December 9, 2026 and as to the remaining 50% on December 9, 2027. The options were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of options.

	/s/ Arlene Morris, by Stephen A. Slusher, Attorney-in-Fact	12/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.